Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate

Detalles Bibliográficos
Autores principales: Fein, Luis, Lazaretti, Nicolas, Chuken, Yamil López, Benfield, J. Rogelio González Ramírez, Mano, Max S., Lobaton, Jose, Korbenfeld, Ernesto, Damian, Fernanda, Lu, Dongrui R., Mori, Ave, Patyna, Shem J., Franco, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514132/
https://www.ncbi.nlm.nih.gov/pubmed/37695417
http://dx.doi.org/10.1007/s40261-023-01305-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514132/
https://www.ncbi.nlm.nih.gov/pubmed/37695417
http://dx.doi.org/10.1007/s40261-023-01305-3

Ejemplares similares